| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_74c0c9a1bc6c87272b3045338ce0a908
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_92d71a3e23389a3bca747290fc6464cf |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-18 |
| filingDate |
2017-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c523acfc4105f218a2036ed10394a9b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce7a6cd5b30e78a61fa6f53fb64b1072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_899d4c34888b01702cb395271e2289d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b81a6d5476ca6efcf7b7b57e30b3c404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a99ee6a614b55b07a4591f8612e1426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8abe2031c58477d6e62c4b32083996d4 |
| publicationDate |
2020-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2020207798-A1 |
| titleOfInvention |
Compound or salt thereof, natural killer t cell activator, and pharmaceutical composition |
| abstract |
The invention provides a compound or a salt thereof capable of activating natural killer T cell, a natural killer T cell activating agent containing such a compound or a salt thereof, and a pharmaceutical composition. The compound of the invention is a compound represented by the following formula (1) or a salt thereof. It is preferable that total carbon number of the number of carbon atoms in the monovalent hydrocarbon group in R 1 in the formula (1) excluding a substitutent and the number of carbon atoms in the divalent hydrocarbon group in X 1 is 5 to 50. The natural killer T cell activating agent contains the aforementioned compound or a salt thereof. The pharmaceutical composition contains the aforementioned compound or a pharmacologically acceptable salt thereof. |
| priorityDate |
2016-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |